Tags

Type your tag names separated by a space and hit enter

Risk factors for HIV seropositivity among people consulting for HIV antibody testing: a pilot surveillance study in Quebec.
CMAJ. 1990 Jul 01; 143(1):25-31.CMAJ

Abstract

The surveillance of AIDS (acquired immune deficiency syndrome) through case reporting only reflects the epidemiologic features of HIV (human immunodeficiency virus) transmission a few years earlier and not the prevalence of HIV seropositivity. HIV infection is not a notifiable condition in Quebec. We were asked by the ministère de la Santé et des Services sociaux du Québec to perform a pilot project for the surveillance of HIV seropositivity using a network of sentinel physicians. From May 15, 1988, to Sept. 30, 1989, physicians from four collaborating centres collected data on the serologic status, demographic characteristics and risk factors for 4209 patients who underwent HIV antibody testing. Of the 3899 subjects included in the study 7.9% were HIV positive. Through logistic regression analysis the following variables were found to be significantly associated with HIV seropositivity: presence of HIV-related symptoms (prevalence odds ratio [POR] 36.5), origin from an endemic area (POR 9.1), homosexuality or bisexuality (POR 8.4), intravenous drug use (POR 4.2), male sex (POR 2.8), previous HIV antibody testing (POR 2.5) and previous sexually transmitted disease (POR 1.8). Over the study period we found a large increase in HIV seroprevalence among intravenous drug users (4.2% in 1988 to 19.0% in 1989) (p = 0.02). This increase might reflect a recent change in the epidemiologic pattern of HIV transmission in Quebec. Surveillance of HIV seropositivity through a network of sentinel physicians may be a reasonable alternative to mandatory reporting.

Authors+Show Affiliations

Département de santé communautaire, Hôpital du Saint-Sacrement, Quebec.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

2357678

Citation

Alary, M, and J Castel. "Risk Factors for HIV Seropositivity Among People Consulting for HIV Antibody Testing: a Pilot Surveillance Study in Quebec." CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne, vol. 143, no. 1, 1990, pp. 25-31.
Alary M, Castel J. Risk factors for HIV seropositivity among people consulting for HIV antibody testing: a pilot surveillance study in Quebec. CMAJ. 1990;143(1):25-31.
Alary, M., & Castel, J. (1990). Risk factors for HIV seropositivity among people consulting for HIV antibody testing: a pilot surveillance study in Quebec. CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne, 143(1), 25-31.
Alary M, Castel J. Risk Factors for HIV Seropositivity Among People Consulting for HIV Antibody Testing: a Pilot Surveillance Study in Quebec. CMAJ. 1990 Jul 1;143(1):25-31. PubMed PMID: 2357678.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Risk factors for HIV seropositivity among people consulting for HIV antibody testing: a pilot surveillance study in Quebec. AU - Alary,M, AU - Castel,J, PY - 1990/7/1/pubmed PY - 1990/7/1/medline PY - 1990/7/1/entrez SP - 25 EP - 31 JF - CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne JO - CMAJ VL - 143 IS - 1 N2 - The surveillance of AIDS (acquired immune deficiency syndrome) through case reporting only reflects the epidemiologic features of HIV (human immunodeficiency virus) transmission a few years earlier and not the prevalence of HIV seropositivity. HIV infection is not a notifiable condition in Quebec. We were asked by the ministère de la Santé et des Services sociaux du Québec to perform a pilot project for the surveillance of HIV seropositivity using a network of sentinel physicians. From May 15, 1988, to Sept. 30, 1989, physicians from four collaborating centres collected data on the serologic status, demographic characteristics and risk factors for 4209 patients who underwent HIV antibody testing. Of the 3899 subjects included in the study 7.9% were HIV positive. Through logistic regression analysis the following variables were found to be significantly associated with HIV seropositivity: presence of HIV-related symptoms (prevalence odds ratio [POR] 36.5), origin from an endemic area (POR 9.1), homosexuality or bisexuality (POR 8.4), intravenous drug use (POR 4.2), male sex (POR 2.8), previous HIV antibody testing (POR 2.5) and previous sexually transmitted disease (POR 1.8). Over the study period we found a large increase in HIV seroprevalence among intravenous drug users (4.2% in 1988 to 19.0% in 1989) (p = 0.02). This increase might reflect a recent change in the epidemiologic pattern of HIV transmission in Quebec. Surveillance of HIV seropositivity through a network of sentinel physicians may be a reasonable alternative to mandatory reporting. SN - 0820-3946 UR - https://www.unboundmedicine.com/medline/citation/2357678/Risk_factors_for_HIV_seropositivity_among_people_consulting_for_HIV_antibody_testing:_a_pilot_surveillance_study_in_Quebec_ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2357678/ DB - PRIME DP - Unbound Medicine ER -